Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-Responders
Clinical trial NCT00697931 · COMPLETED
Trial details
- NCT number
- NCT00697931
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1997-05-01
- Primary completion
- 1998-06-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.